These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

541 related articles for article (PubMed ID: 33664745)

  • 21. Etoposide combined with ruxolitinib for refractory hemophagocytic lymphohistiocytosis during pregnancy: a case report and literature review.
    Wang S; Wu J; Jing X; Zhang Y; Tang H; Wu J
    Hematology; 2019 Dec; 24(1):751-756. PubMed ID: 33138732
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Falciparum malaria-induced secondary hemophagocytic lymphohistiocytosis successfully treated with ruxolitinib.
    Fuchs A; Orth HM; Germing U; Kondakci M; Holtfreter M; Feldt T; Jensen BE; Häussinger D
    Int J Infect Dis; 2020 Nov; 100():382-385. PubMed ID: 32777582
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Cellular and transcriptional impacts of Janus kinase and/or IFN-gamma inhibition in a mouse model of primary hemophagocytic lymphohistiocytosis.
    Albeituni S; Oak N; Tillman HS; Stroh A; Keenan C; Bloom M; Nichols KE
    Front Immunol; 2023; 14():1137037. PubMed ID: 37228616
    [TBL] [Abstract][Full Text] [Related]  

  • 24. A pilot study of ruxolitinib as a front-line therapy for 12 children with secondary hemophagocytic lymphohistiocytosis.
    Zhang Q; Wei A; Ma HH; Zhang L; Lian HY; Wang D; Zhao YZ; Cui L; Li WJ; Yang Y; Wang TY; Li ZG; Zhang R
    Haematologica; 2021 Jul; 106(7):1892-1901. PubMed ID: 32732367
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Ruxolitinib is an alternative to etoposide for patient with hemophagocytic lymphohistiocytosis complicated by acute renal injury: A case report.
    Yan WL; Yang SL; Zhao FY; Xu XJ
    J Oncol Pharm Pract; 2022 Jan; 28(1):222-227. PubMed ID: 34074166
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Ruxolitinib in adult patients with secondary haemophagocytic lymphohistiocytosis: an open-label, single-centre, pilot trial.
    Ahmed A; Merrill SA; Alsawah F; Bockenstedt P; Campagnaro E; Devata S; Gitlin SD; Kaminski M; Cusick A; Phillips T; Sood S; Talpaz M; Quiery A; Boonstra PS; Wilcox RA
    Lancet Haematol; 2019 Dec; 6(12):e630-e637. PubMed ID: 31537486
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Biological therapies for hemophagocytic lymphohistiocytosis: current knowledge and future perspectives.
    He L; Yang C; Wang Y
    Expert Opin Biol Ther; 2023; 23(10):1005-1013. PubMed ID: 37614018
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Mouse Cytomegalovirus Infection in BALB/c Mice Resembles Virus-Associated Secondary Hemophagocytic Lymphohistiocytosis and Shows a Pathogenesis Distinct from Primary Hemophagocytic Lymphohistiocytosis.
    Brisse E; Imbrechts M; Put K; Avau A; Mitera T; Berghmans N; Rutgeerts O; Waer M; Ninivaggi M; Kelchtermans H; Boon L; Snoeck R; Wouters CH; Andrei G; Matthys P
    J Immunol; 2016 Apr; 196(7):3124-34. PubMed ID: 26903481
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Recent advances in the treatment of hemophagocytic lymphohistiocytosis and macrophage activation syndrome.
    Jesudas R; Nichols KE
    Curr Opin Allergy Clin Immunol; 2022 Dec; 22(6):364-370. PubMed ID: 36206094
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Low dose ruxolitinib plus HLH-94 protocol: A potential choice for secondary HLH.
    Wang H; Gu J; Liang X; Mao X; Wang Z; Huang W
    Semin Hematol; 2020 Jan; 57(1):26-30. PubMed ID: 32690141
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Repression of interferon β-regulated cytokines by the JAK1/2 inhibitor ruxolitinib in inflammatory human macrophages.
    Febvre-James M; Lecureur V; Augagneur Y; Mayati A; Fardel O
    Int Immunopharmacol; 2018 Jan; 54():354-365. PubMed ID: 29202299
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Ruxolitinib treatment permits lower cumulative glucocorticoid dosing in children with secondary hemophagocytic lymphohistiocytosis.
    Chi Y; Liu R; Zhou ZX; Shi XD; Ding YC; Li JG
    Pediatr Rheumatol Online J; 2021 Apr; 19(1):49. PubMed ID: 33794928
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Hemophagocytic syndromes (HPSs) including hemophagocytic lymphohistiocytosis (HLH) in adults: A systematic scoping review.
    Hayden A; Park S; Giustini D; Lee AY; Chen LY
    Blood Rev; 2016 Nov; 30(6):411-420. PubMed ID: 27238576
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Specific cytokine patterns in Epstein-Barr virusassociated hemophagocytic lymphohistiocytosis compared to Kawasaki disease in children.
    Yang Y; Yu H; Li C; Gui Z; Chang Y
    Pediatr Hematol Oncol; 2023; 40(6):529-538. PubMed ID: 37178062
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Acute kidney injury in critical care: complications of hemophagocytic lymphohistiocytosis.
    Zhao M; Guan Y; Lin J; Qiu Y; Zhao S; Duan M
    Front Immunol; 2024; 15():1396124. PubMed ID: 38957461
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Simple Evaluation of Clinical Situation and Subtypes of Pediatric Hemophagocytic Lymphohistiocytosis by Cytokine Patterns.
    Xu XJ; Luo ZB; Song H; Xu WQ; Henter JI; Zhao N; Wu MH; Tang YM
    Front Immunol; 2022; 13():850443. PubMed ID: 35296096
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Ruxolitinib combined with doxorubicin, etoposide, and dexamethasone for the treatment of the lymphoma-associated hemophagocytic syndrome.
    Zhou L; Liu Y; Wen Z; Yang S; Li M; Zhu Q; Qiu S; Gao Y; Wang H; Yuan Y; Zhang H; Chen C; Zeng W; Guan Z; Pan X
    J Cancer Res Clin Oncol; 2020 Nov; 146(11):3063-3074. PubMed ID: 32617699
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Etoposide Therapy of Cytokine Storm Syndromes.
    Henter JI; von Bahr Greenwood T
    Adv Exp Med Biol; 2024; 1448():525-551. PubMed ID: 39117837
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Alleviating the storm: ruxolitinib in HLH.
    La Rosée P
    Blood; 2016 Mar; 127(13):1626-7. PubMed ID: 27034417
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Biomarkers for Early Diagnosis of Hemophagocytic Lymphohistiocytosis in Critically Ill Patients.
    Debaugnies F; Mahadeb B; Nagant C; Meuleman N; De Bels D; Wolff F; Gottignies P; Salaroli A; Borde P; Voué M; Corazza F
    J Clin Immunol; 2021 Apr; 41(3):658-665. PubMed ID: 33417087
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 28.